Heart Failure Beat Healthy Living: The Importance of Knowing Your Risk for Related Conditions

The Importance of Knowing Your Risk for Related Conditions

There are many conditions and diseases that can be associated with your heart failure diagnosis. While diabetes and high blood pressure are common, infiltrative cardiomyopathy and severe lung disease are also possible. Tune in to this podcast episode to learn how to recognize your risk for related conditions and know what conversations you should be having with your doctor.

Listen below and subscribe: Apple Podcasts, Google Podcasts, Spotify, Podcast Home

HostLucianne (Lucy) West, PharmD, Clinical Pharmacy Specialist at Tufts Medical Center 


  • Nancy Albert, PhD, CCNS, CCRN, NE-BC, Associate Chief Nursing Officer of the Office of Research and Innovation for the Cleveland Clinic Health System, and Clinical Nurse Specialist at the Kaufman Center for Heart Failure. She is also the former president of HFSA.

  • Ahmad Masri, MD, MS, Associate Professor of Medicine at Oregon Health & Science University

  • Mitch Psotka, MD, PhD, Section Chief of Heart Failure and Transplant and Director of the Infiltrative Cardiomyopathy Center at the Inova Heart and Vascular Institute


This episode is sponsored in part by Heart Failure Awareness 365 program sponsor Renovacor.

Renovacor is a biotechnology company committed to delivering innovative precision therapies to improve the lives of patients and families battling genetically-driven cardiovascular and mechanistically-related diseases. 
Renovacor was founded by renowned Cardiologist and Heart Failure Expert, Dr. Art Feldman. 
Since its founding, Renovacor has been working towards the development of gene therapies for BAG3- associated dilated cardiomyopathy (or BAG3-DCM) and genetic segments of Arrhythmogenic Cardiomyopathy (or ACM). By researching and developing medicines that target the underlying cause of disease, Renovacor’s vision is to bring life-changing therapies to patients living with serious genetic cardiovascular and related diseases.


HFSA does not endorse any of the following medications or treatments discussed in this episode: Entresto, Farxiga, Jardiance